查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561423

2024-2032 年按類型、製造商類型、合成技術、給藥途徑、應用和地區分類的胜肽治療市場報告

Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2023年全球胜肽治療IMARC Group規模達428億美元。

胜肽是有效的選擇性訊號分子，可與特定的細胞表面受體（例如離子通道和 G 蛋白偶聯受體 (GPCR)）結合並觸發細胞內效應。他們在製藥業受僱設計新型再生療法，可以針對多種細胞並操縱它們的反應。與其他治療方案相比，這些療法毒性較小、相對安全且耐受性良好。因此，它們在世界各地治療癌症、損傷、傳染病、代謝紊亂和美學問題的臨床實踐中越來越受歡迎。

胜肽治療市場趨勢：

急性和慢性疾病的日益流行，以及醫療設施的普及，是積極影響胜肽開發創新療法需求的主要因素之一。此外，肽療法用於藥妝手術以減緩皮膚老化的過程。再加上人們對外表的意識不斷增強以及對保持年輕健康皮膚的渴望，正在推動整容手術和胜肽療法在世界各地的採用。除此之外，隨著減少注射頻率、提高穩定性和其他物理特性的新型合成策略的引入，肽療法被廣泛用於糖尿病患者的注射。這與糖尿病發病率的增加以及對快速和精確治療方法的日益偏好相結合，正在影響胜肽療法相對於口服藥物的使用。此外，個人化和標靶治療的新興趨勢正在催化對多功能胜肽基材料的需求。再加上開發用於治療自體免疫和發炎疾病的新型胜肽療法的資金不斷增加，預計將創造積極的市場前景。

本報告回答的關鍵問題

  • 全球肽治療市場有多大？ 2024-2032年全球胜肽治療市場的預期成長率是多少？
  • 推動全球胜肽治療市場的關鍵因素是什麼？
  • COVID-19 對全球胜肽治療市場有何影響？
  • 全球肽治療市場按類型分類是怎樣的？
  • 根據製造商類型，全球胜肽治療市場的詳細情形如何？
  • 基於合成技術的全球胜肽治療市場的詳細情形如何？
  • 根據給藥途徑，全球胜肽治療市場的詳細情形如何？
  • 根據應用，全球胜肽治療市場的細分如何？
  • 全球胜肽治療市場的關鍵區域有哪些？
  • 誰是全球胜肽治療市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球胜肽治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 創新的
    • 市場趨勢
    • 市場預測
  • 通用的
    • 市場趨勢
    • 市場預測

第 7 章：市場細分：按製造商類型

  • 外包
    • 市場趨勢
    • 市場預測
  • 內部
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：透過合成技術

  • 固相胜肽合成
    • 市場趨勢
    • 市場預測
  • 液相胜肽合成
    • 市場趨勢
    • 市場預測
  • 混合技術
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：依管理途徑

  • 注射用
    • 市場趨勢
    • 市場預測
  • 口服
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按應用

  • 胃腸道疾病
    • 市場趨勢
    • 市場預測
  • 神經系統疾病
    • 市場趨勢
    • 市場預測
  • 代謝紊亂
    • 市場趨勢
    • 市場預測
  • 癌症
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amgen Inc.
    • Apitope International NV
    • Arch Biopartners Inc.
    • AstraZeneca plc
    • Circle Pharma Inc.
    • Corden Pharma GmbH
    • F. Hoffmann-La Roche AG
    • Ipsen Group
    • Lonza Group AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Teva Pharmaceuticals Industries Ltd.
    • Zealand Pharma A/S
Product Code: SR112024A4510

The global peptide therapeutics market size reached US$ 42.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 86.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.

Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Peptide Therapeutics Market Trends:

The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.

Breakup by Type:

  • Innovative
  • Generic

Breakup by Type of Manufacturer:

  • Outsourced
  • In-house

Breakup by Synthesis Technology:

  • Solid Phase Peptide Synthesis
  • Liquid Phase Peptide Synthesis
  • Hybrid Technology

Breakup by Routes of Administration:

  • Parenteral
  • Oral
  • Others

Breakup by Application:

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Metabolic Disorders
  • Cancer
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.

Key Questions Answered in This Report

  • 1. How big is the global peptide therapeutics market?
  • 2. What is the expected growth rate of the global peptide therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global peptide therapeutics market?
  • 4. What has been the impact of COVID-19 on the global peptide therapeutics market?
  • 5. What is the breakup of the global peptide therapeutics market based on the type?
  • 6. What is the breakup of the global peptide therapeutics market based on the type of manufacturer?
  • 7. What is the breakup of the global peptide therapeutics market based on the synthesis technology?
  • 8. What is the breakup of the global peptide therapeutics market based on the routes of administration?
  • 9. What is the breakup of the global peptide therapeutics market based on the application?
  • 10. What are the key regions in the global peptide therapeutics market?
  • 11. Who are the key players/companies in the global peptide therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peptide Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Innovative
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Generic
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type of Manufacturer

  • 7.1 Outsourced
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 In-house
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Synthesis Technology

  • 8.1 Solid Phase Peptide Synthesis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquid Phase Peptide Synthesis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hybrid Technology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Routes of Administration

  • 9.1 Parenteral
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Gastrointestinal Disorders
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Neurological Disorders
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Metabolic Disorders
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Cancer
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Amgen Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Apitope International NV
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Arch Biopartners Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 AstraZeneca plc
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Circle Pharma Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Corden Pharma GmbH
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 F. Hoffmann-La Roche AG
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 SWOT Analysis
    • 16.3.8 Ipsen Group
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Lonza Group AG
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Novo Nordisk A/S
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Pfizer Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Teva Pharmaceuticals Industries Ltd.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Zealand Pharma A/S
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials

List of Figures

  • Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2023
  • Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2023
  • Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2023
  • Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
  • Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
  • Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2024-2032
  • Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million US$), 2024-2032
  • Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million US$), 2024-2032
  • Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Peptide Therapeutics Market: Competitive Structure
  • Table 9: Global: Peptide Therapeutics Market: Key Players